A pilot study of cranial electrotherapy stimulation for generalized anxiety disorder.
暂无分享,去创建一个
Jamie Feusner | Alexander Bystritsky | Jamie D. Feusner | A. Bystritsky | Lauren Kerwin | Lauren E Kerwin
[1] Jennifer Corns. The placebo effect , 2018, Philosophy of Pain.
[2] T. Müller,et al. Anxiolytic effect of rescue remedy for psychiatric patients: a double-blind, placebo-controlled, randomized trial. , 2006, Journal of clinical psychopharmacology.
[3] K. Vonck,et al. Vagus nerve stimulation and cognition , 2006, Seizure.
[4] C. Sherbourne,et al. Assessment of beliefs about psychotropic medication and psychotherapy: development of a measure for patients with anxiety disorders. , 2005, General hospital psychiatry.
[5] Tor D. Wager,et al. Expectations and anxiety as mediators of placebo effects in pain , 2005, Pain.
[6] D. Stein,et al. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram , 2004, BMC psychiatry.
[7] Rudolf Hoehn-Saric,et al. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study. , 2004, Archives of general psychiatry.
[8] C. Shealy,et al. Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression. , 2003, Journal of alternative and complementary medicine.
[9] M. Tansella,et al. Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. , 2003, Journal of affective disorders.
[10] D. Sheehan,et al. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. , 2003, The American journal of psychiatry.
[11] J. Leite,et al. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo‐controlled pilot study , 2002, Phytotherapy research : PTR.
[12] R. Kessler,et al. Patterns and correlates of generalized anxiety disorder in community samples. , 2002, The Journal of clinical psychiatry.
[13] R. E. Barr,et al. Quantitative analysis of the electroencephalogram during cranial electrotherapy stimulation , 2001, Clinical Neurophysiology.
[14] M. Pollack,et al. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. , 2001, The Journal of clinical psychiatry.
[15] R. Kessler,et al. The epidemiology of generalized anxiety disorder. , 2001, The Psychiatric clinics of North America.
[16] K. Rickels,et al. Overview and clinical presentation of generalized anxiety disorder. , 2001, The Psychiatric clinics of North America.
[17] R. Kessler,et al. The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research , 2000, Acta psychiatrica Scandinavica. Supplementum.
[18] S. Beck,et al. Folinic acid reduces cleft lip [CL(P)] in A/WySn mice. , 1999, Teratology.
[19] J. Matson,et al. Reliability of the Matson Evaluation of Drug Side Effects Scale (MEDS). , 1998, Research in developmental disabilities.
[20] G. Emilien,et al. Use of a placebo in clinical trials , 1998, European Psychiatry.
[21] A. Schatzberg,et al. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders , 1998, British Journal of Psychiatry.
[22] T. Baghai,et al. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients , 1998, Psychopharmacology.
[23] R. Lydiard,et al. Biological basis of generalized anxiety disorder. , 1997, The Journal of clinical psychiatry.
[24] F. X. Bostick,et al. Potential and current density distributions of cranial electrotherapy stimulation (CES) in a four-concentric-spheres model , 1996, IEEE Transactions on Biomedical Engineering.
[25] K. Rickels,et al. Placebo‐controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder , 1995, International clinical psychopharmacology.
[26] T. Chalmers,et al. Meta‐Analysis of Randomized Controlled Trials of Cranial Electrostimulation: Efficacy in Treating Selected Psychological and Physiological Conditions , 1995, The Journal of nervous and mental disease.
[27] J. Yager,et al. Psychometric discrimination between anxiety and depression. , 1993, The Journal of nervous and mental disease.
[28] D. Shapiro,et al. Continuous physiological changes and subjective reports in panic patients: A preliminary methodological report , 1992, Biological Psychiatry.
[29] F. Okada. “Reverse Placebo Effects”: Anticipation/Anxiety at the Possibility of Receiving Placebos , 1992, The Annals of pharmacotherapy.
[30] Monte S. Buchsbaum,et al. PET in generalized anxiety disorder , 1991, Biological Psychiatry.
[31] J. Vincent,et al. Efficiency of transcranial electrostimulation on anxiety and insomnia symptoms during a washout period in depressed patients a double-blind study , 1991, Biological Psychiatry.
[32] S. Solomon,et al. Safety and Effectiveness of Cranial Electrotherapy in the Treatment of Tension Headache , 1989, Headache.
[33] R. Noyes,et al. Generalized anxiety disorder. , 1987, Primary care.
[34] M S Buchsbaum,et al. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. , 1987, Life sciences.
[35] E. Boyd,et al. Cranial electrotherapy stimulation as a treatment for anxiety in chemically dependent persons. , 1986, Alcoholism, clinical and experimental research.
[36] W. B. Jarzembski. Electrical stimulation and substance abuse treatment. , 1985, Neurobehavioral toxicology and teratology.
[37] H. Frazier,et al. Cranial electrotherapy stimulation treatment of cognitive brain dysfunction in chemical dependence. , 1984, The Journal of clinical psychiatry.
[38] W. Guy. Patient assessment in clinical trials , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[39] C. S. Mellor,et al. A double-blind study of electrosleep for anxiety and insomnia. , 1975, Biological psychiatry.
[40] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[41] M. Segal,et al. A clinical comparison study of the effects of reserpine and placebo on anxiety. , 1959, A.M.A. archives of neurology and psychiatry.
[42] M. Hamilton. The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.
[43] M. Fenichel,et al. Electrosleep therapy in psychoses. , 1957, Diseases of the nervous system.
[44] E. Arian. [Electrosleep; clinical experiences]. , 1957, Minerva medica.
[45] J. Davidson,et al. Pharmacotherapy of generalized anxiety disorder. , 2001, The Journal of clinical psychiatry.
[46] M. Pollack. Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission. , 2001, The Journal of clinical psychiatry.
[47] Daniel L. Kirsch,et al. The use of cranial electrotherapy stimulation in the management of chronic pain: A review. , 2000, NeuroRehabilitation.
[48] D. Sheehan,et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.
[49] A. Bystritsky,et al. Four-dimensional Anxiety and Depression Scale: a preliminary psychometric report. , 1996, Anxiety.
[50] J. Marshall,et al. The use of cranial electrotherapy stimulation in the treatment of closed-head-injured patients. , 1994, Brain injury.
[51] V P Lebedev,et al. The administration of transcranial electric treatment for affective disturbances therapy in alcoholic patients. , 1991, Drug and alcohol dependence.
[52] A. Flemenbaum. Cerebral electrotherapy (electrosleep): a review. , 1975, Current psychiatric therapies.
[53] A. Flemenbaum. Cerebral electrotherapy (electrosleep): an open-clinical study with a six month follow-up. , 1974, Psychosomatics.
[54] Electrosleep and cerebral electrotherapy. , 1971, The Medical letter on drugs and therapeutics.
[55] R. C. Long. Electrosleep therapy. Some results with the use of electrically induced sleep in the treatment of psychiatric patients. , 1966, The Journal of the Kansas Medical Society.